BELL STEVEN J 4/A
4/A · BIOSANTE PHARMACEUTICALS INC · Filed Aug 25, 2005
Insider Transaction Report
Form 4/AAmended
BELL STEVEN J
VP Research & Pre-Clinical Dev
Transactions
- Award
Employee Stock Option (right to buy)
2005-07-19+25,000→ 25,000 totalExercise: $3.71Exp: 2015-07-18→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option vests (i) with respect to 5,000 shares on each of January 19, 2006 and July 19, 2006 and (ii) with respect to 7,500 shares on each of July 19, 2007 and July 19, 2008.